Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hepatitis A Vaccines
New hepatitis a vaccines study results from Pontificia University Catolica of Chile described
June 25th, 2008
New investigation results, 'Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children,' are detailed in a study published in International Journal of Infectious Diseases. In this recent study, researchers in Santiago, Chile conducted a study "To compare the immunogenicity, safety, and interchangeability of two pediatric hepatitis A vaccines, Avaxim 80U-Pediatric and Havrix 720, in Chilean children. In this randomized trial, 332 hepatitis A virus (HAV) seronegative children from 1 to 15 years of age received two doses of Avaxim, two doses of Havrix, or Havrix followed by Avaxim, 6 months apart." "Anti-HAV antibody...
Source: Vaccine Weekly (2008-06-25)
|
